Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Head and Neck Cancer |
Free Subscription
11 BMC Cancer |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Head and Neck Cancer is free of charge.
Efficacy and safety of Zolbetuximab plus chemotherapy for advanced
CLDN18.2-positive gastric or gastro-oesophageal adenocarcinoma: a meta-analysis
of randomized clinical trials.
BMC Cancer. 2024;24:240.
PubMed
Abstract available
Development of a nomogram for prediction of central lymph node metastasis of
papillary thyroid microcarcinoma.
BMC Cancer. 2024;24:235.
PubMed
Abstract available
p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing
head and neck cancer.
BMC Cancer. 2024;24:233.
PubMed
Abstract available
Metabolic subtypes and immune landscapes in esophageal squamous cell carcinoma:
prognostic implications and potential for personalized therapies.
BMC Cancer. 2024;24:230.
PubMed
Abstract available
The association of HBV infection and head and neck cancer: a systematic review
and meta-analysis.
BMC Cancer. 2024;24:225.
PubMed
Abstract available
The prognostic role of single cell invasion and nuclear diameter in early oral
tongue squamous cell carcinoma.
BMC Cancer. 2024;24:213.
PubMed
Abstract available
The association of E2F1 and E2F2 single nucleotide polymorphisms with laryngeal
squamous cell carcinoma pathomorphological features.
BMC Cancer. 2024;24:214.
PubMed
Abstract available
SIRT7 promotes the proliferation and migration of anaplastic thyroid cancer cells
by regulating the desuccinylation of KIF23.
BMC Cancer. 2024;24:210.
PubMed
Abstract available
A nomogram for predicting adverse pathologic features in low-risk papillary
thyroid microcarcinoma.
BMC Cancer. 2024;24:244.
PubMed
Abstract available
Combined score based on plasma fibrinogen and platelet-lymphocyte ratio as a
prognostic biomarker in esophageal squamous cell carcinoma.
BMC Cancer. 2024;24:249.
PubMed
Abstract available
Mechanism of intestinal microbiota disturbance promoting the occurrence and
development of esophageal squamous cell carcinoma--based on microbiomics and
metabolomics.
BMC Cancer. 2024;24:245.
PubMed
Abstract available
Perioperative corticosteroids for reducing postoperative complications following
esophagectomy: an updated systematic review and meta-analysis.
BMC Surg. 2024;24:57.
PubMed
Abstract available
The clinical implication and translational research of OSCC differentiation.
Br J Cancer. 2024;130:660-670.
PubMed
Abstract available
Cancer-related fatigue trajectories up to 5 years after curative treatment for
oesophageal cancer.
Br J Cancer. 2024;130:628-637.
PubMed
Abstract available
A phase 2 study of MK-2206 in patients with incurable adenoid cystic carcinoma
(Alliance A091104).
Cancer. 2024;130:702-712.
PubMed
Abstract available
Shortened telomere length in peripheral blood leukocytes is associated with
cumulative radioactive iodine doses in patients with differentiated thyroid
carcinoma.
Cancer. 2024 Feb 20. doi: 10.1002/cncr.35256.
PubMed
Abstract available
Integrative multi-omics analysis reveals different metabolic phenotypes based on
molecular characteristics in thyroid cancer.
Clin Cancer Res. 2023 Dec 13. doi: 10.1158/1078-0432.CCR-23-2025.
PubMed
Abstract available
Uptake of 99mTc-DTPA in Bone Metastases From Follicular Thyroid Carcinoma.
Clin Nucl Med. 2024 Feb 7. doi: 10.1097/RLU.0000000000005100.
PubMed
Abstract available
Diffuse Bone Uptake of 131I and Effect on Blood Counts in a Patient With
Papillary Thyroid Carcinoma and Chronic Lymphocytic Leukemia.
Clin Nucl Med. 2024 Feb 12. doi: 10.1097/RLU.0000000000005119.
PubMed
Abstract available
What goes around, comes around: circumferential endoscopic submucosal dissection
and stricture.
Gastrointest Endosc. 2024;99:346-348.
PubMed
Endoscopic resection of giant esophageal subepithelial lesions: experience from a
large tertiary center.
Gastrointest Endosc. 2024;99:358-370.
PubMed
Abstract available
Complete circumferential endoscopic submucosal dissection for early Barrett's
neoplasia.
Gastrointest Endosc. 2024;99:337-345.
PubMed
Abstract available
Immunotherapy targeting tumor-associated antigen in a mouse model of head and
neck cancer.
Head Neck. 2024 Feb 23. doi: 10.1002/hed.27703.
PubMed
Abstract available
Clinical outcomes of cetuximab-based treatment for distant metastatic head and
neck squamous cell carcinoma: A real-world study using Taiwan Head Neck Society
registry database.
Head Neck. 2024 Feb 22. doi: 10.1002/hed.27681.
PubMed
Abstract available
Monoamine oxidase B inhibits epithelial-mesenchymal transition and trigger
apoptosis via targeting ERK1/2 signaling pathway in head and neck squamous cell
carcinoma.
Head Neck. 2024 Feb 20. doi: 10.1002/hed.27697.
PubMed
Abstract available
Neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent
chemoradiotherapy alone in elderly patients with stage III-IVa nasopharyngeal
carcinoma: A real-world study based on medical comorbidities.
Head Neck. 2024 Feb 17. doi: 10.1002/hed.27689.
PubMed
Abstract available
Effect of waiting time for radiotherapy after last induction chemotherapy on
prognosis of locally advanced nasopharyngeal carcinoma.
Head Neck. 2024 Feb 17. doi: 10.1002/hed.27680.
PubMed
Abstract available
Disease control and late toxicity in Adaptive Dose Painting by Numbers vs.
non-adaptive radiotherapy for head and neck cancer: a randomized controlled phase
II trial.
Int J Radiat Oncol Biol Phys. 2024 Feb 20:S0360-3016(24)00025.
PubMed
Abstract available
Voxel-level dosimetry for combined Iodine-131 radiopharmaceutical therapy and
external beam radiotherapy treatment paradigms of head and neck cancer.
Int J Radiat Oncol Biol Phys. 2024 Feb 15:S0360-3016(24)00308.
PubMed
Abstract available
Nonalcoholic Fatty Liver Disease and the Risk of Thyroid Cancer Among Young
Adults in South Korea.
J Clin Endocrinol Metab. 2023 Oct 31:dgad575. doi: 10.1210.
PubMed
Abstract available
Prognostic Factors Improving ATA Risk System and Dynamic Risk Stratification in
Low- and Intermediate-Risk DTC Patients.
J Clin Endocrinol Metab. 2024;109:722-729.
PubMed
Abstract available
Effect of radioactive iodine therapy on cancer-specific survival of papillary
thyroid cancer tall cell variant.
J Clin Endocrinol Metab. 2023 Oct 7:dgad580. doi: 10.1210.
PubMed
Abstract available
Pregnancy and progression of differentiated thyroid cancer: A propensity
score-matched retrospective cohort study.
J Clin Endocrinol Metab. 2023 Sep 20:dgad557. doi: 10.1210.
PubMed
Abstract available
A novel remote assessment pathway to streamline the management of two-week-wait
suspected head and neck cancer referrals: a prospective analysis of 660 patients.
J Laryngol Otol. 2024 Jan 19:1-5. doi: 10.1017/S002221512400015.
PubMed
Abstract available
Clinical Evaluation of Deep Learning for Tumor Delineation on (18)F-FDG PET/CT of
Head and Neck Cancer.
J Nucl Med. 2024 Feb 22:jnumed.123.266574. doi: 10.2967/jnumed.123.266574.
PubMed
Abstract available
Decisional Conflict in Patients with Advanced Laryngeal Carcinoma: A Multicenter
Study.
Laryngoscope. 2024 Feb 17. doi: 10.1002/lary.31336.
PubMed
Abstract available
A Minimally Invasive Endoscopic Transnasal and Transorbital Approach to Sinonasal
Tumor Resection.
Laryngoscope. 2024;134:1308-1312.
PubMed
Abstract available
Molecular Factors in Carcinoma Ex Pleomorphic Adenoma: Systematic Review and
Meta-Analysis.
Laryngoscope. 2024;134:1042-1053.
PubMed
Abstract available
Incidental Thyroid Tissue in Sentinel Nodes From Oral Squamous Cell Carcinoma.
Laryngoscope. 2024;134:1278-1281.
PubMed
Abstract available
Glomangiopericytoma Presenting as a Middle Ear Mass.
Laryngoscope. 2023 Aug 24. doi: 10.1002/lary.30987.
PubMed
Abstract available
Fluorescent Guided Sentinel Lymph Mapping of the Oral Cavity with
Fluorescent-Labeled Tilmanocept.
Laryngoscope. 2024;134:1299-1307.
PubMed
Abstract available
Efficacy and safety of cadonilimab in previously treated recurrent or metastatic
nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study.
Oral Oncol. 2024;151:106723.
PubMed
Abstract available
Comments on the article titled "Factors associated with unknown primary status in
head and neck squamous cell carcinoma": Is the N status the overlooked elephant
in the room?
Oral Oncol. 2024;151:106727.
PubMed
Tumor volume instead of recurrent T category predicts clinical outcome of
patients with locally recurrent nasopharyngeal carcinoma salvaged by carbon ion
radiation therapy.
Oral Oncol. 2024;151:106683.
PubMed
Abstract available
ARID1A loss is associated with increased NRF2 signaling in human head and neck
squamous cell carcinomas.
PLoS One. 2024;19:e0297741.
PubMed
Abstract available
The value of subcutaneous xenografts for individualised radiotherapy in HNSCC:
Robust gene signature correlates with radiotherapy outcome in patients and
xenografts.
Radiother Oncol. 2024;191:110055.
PubMed
Abstract available
Sole brachytherapy for inoperable, recurrent, and irradiated salivary gland
cancer.
Radiother Oncol. 2024;190:110022.
PubMed
Abstract available
Response to the letter-to-the-editor "Comments on: Accounting for fractionation
and heterogeneous dose distributions in the modelling of osteoradionecrosis in
oropharyngeal carcinoma treatment".
Radiother Oncol. 2024;190:110036.
PubMed
Comments on "Accounting for fractionation and heterogeneous dose distributions in
the modelling of osteoradionecrosis in oropharyngeal carcinoma treatment".
Radiother Oncol. 2024;190:110035.
PubMed
Progression of cognitive dysfunction in NPC survivors with radiation-induced
brain necrosis: A prospective cohort.
Radiother Oncol. 2024;190:110033.
PubMed
Abstract available
Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC
& MARCH meta-analyses.
Radiother Oncol. 2024;190:110011.
PubMed
Abstract available
Curative carbon ion radiotherapy in a head and neck mucosal melanoma series:
Facing the future within multidisciplinarity.
Radiother Oncol. 2024;190:110003.
PubMed
Abstract available
Low contralateral failure rate with unilateral proton beam radiotherapy for
oropharyngeal squamous cell carcinoma: A multi-institutional prospective study
from the proton collaborative group.
Radiother Oncol. 2024;190:109977.
PubMed
Abstract available
The individualized delineation of clinical target volume for primary
nasopharyngeal carcinoma based on invasion risk of substructures: A prospective,
real-word study with a large population.
Radiother Oncol. 2024;194:110154.
PubMed
Abstract available
Early regression index (ERI) on MR images as response predictor in esophageal
cancer treated with neoadjuvant chemo-radiotherapy: Interim analysis of the
prospective ESCAPE trial.
Radiother Oncol. 2024;194:110160.
PubMed
Abstract available
Response to letter to the editor regarding "External validation of a lung
cancer-based prediction model for two-year mortality in esophageal cancer patient
cohorts" by M. Berbee et al.
Radiother Oncol. 2024 Feb 17:110176. doi: 10.1016/j.radonc.2024.110176.
PubMed
Characterization of the thyroid cancer genomic landscape by plasma-based
circulating tumor DNA next-generation sequencing.
Thyroid. 2023 Nov 14. doi: 10.1089/thy.2023.0204.
PubMed
Abstract available
Social Vulnerability Association with Thyroid Cancer Disparities in the United
States.
Thyroid. 2023 Dec 9. doi: 10.1089/thy.2023.0370.
PubMed
Abstract available
Assessing Fear of Thyroid Cancer in the General U.S. Population: A
Cross-Sectional Study.
Thyroid. 2023 Dec 19. doi: 10.1089/thy.2023.0479.
PubMed
Abstract available
Association between eight autoimmune diseases and thyroid cancer: A Nationwide
Cohort Study.
Thyroid. 2023 Dec 27. doi: 10.1089/thy.2023.0353.
PubMed
Abstract available
All-cause and cause-specific mortality among low-risk differentiated thyroid
cancer survivors in the United States.
Thyroid. 2023 Dec 27. doi: 10.1089/thy.2023.0449.
PubMed
Abstract available
Thank you for your interest in scientific medicine.